BioRadar Co-Founder and CEO Dr. Ashish K. Jha published an op-ed in STAT News on March 25, 2026, warning that America's current biosurveillance systems are fundamentally unprepared for the threat of novel or engineered pathogens.

Dr. Jha argues that the systems the U.S. relies on today — syndromic surveillance, emergency department reporting, and wastewater monitoring — were built to recognize diseases we already know. An engineered agent or a never-before-seen pathogen would likely be missed entirely, circulating for days or weeks before generating a detectable signal.

"By the time it is showing up in emergency rooms, it has likely already seeded transmission chains across multiple cities," Dr. Jha writes. "The window for containment isn't just smaller — it may already be closed."

The piece comes as BioRadar is building the infrastructure to close exactly this gap — a continuously operating, AI-enabled biological intelligence service capable of detecting known pathogens, new variants, and previously unknown or engineered threats in real time.

Read the Full Op-Ed in STAT News →BioRadar Co-Founder and CEO Dr. Ashish K. Jha published an op-ed in STAT News on March 25, 2026, warning that America's current biosurveillance systems are fundamentally unprepared for the threat of novel or engineered pathogens.

Dr. Jha argues that the systems the U.S. relies on today — syndromic surveillance, emergency department reporting, and wastewater monitoring — were built to recognize diseases we already know. An engineered agent or a never-before-seen pathogen would likely be missed entirely, circulating for days or weeks before generating a detectable signal.

"By the time it is showing up in emergency rooms, it has likely already seeded transmission chains across multiple cities," Dr. Jha writes. "The window for containment isn't just smaller — it may already be closed."

The piece comes as BioRadar is building the infrastructure to close exactly this gap — a continuously operating, AI-enabled biological intelligence service capable of detecting known pathogens, new variants, and previously unknown or engineered threats in real time.

Read the Full Op-Ed in STAT News →